Greenwich LifeSciences Statistics
Total Valuation
GLSI has a market cap or net worth of $162.86 million. The enterprise value is $157.04 million.
| Market Cap | 162.86M |
| Enterprise Value | 157.04M |
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
GLSI has 13.14 million shares outstanding. The number of shares has increased by 1.49% in one year.
| Current Share Class | 13.14M |
| Shares Outstanding | 13.14M |
| Shares Change (YoY) | +1.49% |
| Shares Change (QoQ) | +1.83% |
| Owned by Insiders (%) | 54.94% |
| Owned by Institutions (%) | 9.43% |
| Float | 5.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 32.69 |
| P/TBV Ratio | 32.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.91
| Current Ratio | 6.91 |
| Quick Ratio | 6.91 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -151.72% and return on invested capital (ROIC) is -97.25%.
| Return on Equity (ROE) | -151.72% |
| Return on Assets (ROA) | -89.85% |
| Return on Capital (ROIC) | -97.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.50M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.58% in the last 52 weeks. The beta is 3.23, so GLSI's price volatility has been higher than the market average.
| Beta (5Y) | 3.23 |
| 52-Week Price Change | +20.58% |
| 50-Day Moving Average | 13.57 |
| 200-Day Moving Average | 14.65 |
| Relative Strength Index (RSI) | 39.27 |
| Average Volume (20 Days) | 32,264 |
Short Selling Information
The latest short interest is 490,366, so 3.73% of the outstanding shares have been sold short.
| Short Interest | 490,366 |
| Short Previous Month | 470,741 |
| Short % of Shares Out | 3.73% |
| Short % of Float | 8.28% |
| Short Ratio (days to cover) | 21.41 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.76M |
| Pretax Income | -9.24M |
| Net Income | -10.50M |
| EBITDA | -10.76M |
| EBIT | -10.76M |
| Earnings Per Share (EPS) | -$0.81 |
Balance Sheet
| Cash & Cash Equivalents | 5.82M |
| Total Debt | n/a |
| Net Cash | 5.82M |
| Net Cash Per Share | $0.44 |
| Equity (Book Value) | 4.98M |
| Book Value Per Share | 0.38 |
| Working Capital | 4.98M |
Cash Flow
| Operating Cash Flow | -7.57M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.57M |
| FCF Per Share | -$0.58 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GLSI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.49% |
| Shareholder Yield | -1.49% |
| Earnings Yield | -6.44% |
| FCF Yield | -4.65% |
Analyst Forecast
The average price target for GLSI is $38.00, which is 206.70% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $38.00 |
| Price Target Difference | 206.70% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |